Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Se Ik Kim

Showing results (101-110 of 138) with videos related to

Pageof 14
Sort By:
Gynecologic Oncology|April 27, 2023
Conization before radical hysterectomy in patients with early-stage cervical cancer: A Korean multicenter study (COBRA-R)Se Ik Kim, So Hyun Nam, Suhyun Hwangbo, et al.
Cancer Letters|May 15, 2022
Integrated analysis of ascites and plasma extracellular vesicles identifies a miRNA-based diagnostic signature in ovarian cancerWenyu Wang, HyunA Jo, Sangick Park, et al.
Journal of Gynecologic Oncology|May 2, 2025
Current status and challenges in training the next generation of gynecologic cancer care providers in AsiaJyoti Meena, Dipanwita Banerjee, Se Ik Kim, et al.
Annals of Surgical Oncology|June 11, 2015
Comparison of Lower Extremity Edema in Locally Advanced Cervical Cancer: Pretreatment Laparoscopic Surgical Staging with Tailored Radiotherapy Versus Primary RadiotherapySe Ik Kim, Myong Cheol Lim, Jeong Seon Lee, et al.
BMC Cancer|November 23, 2021
Survival impact of additional chemotherapy after adjuvant concurrent chemoradiation in patients with early cervical cancer who underwent radical hysterectomySe Ik Kim, Jeong Yun Kim, Chan Woo Wee, et al.
Cancer Research and Treatment|March 21, 2025
Efficacy of Chemotherapy Following Prior PARP-Inhibitor Treatment in Patients with Ovarian CancerJung Chul Kim, Junsik Park, Yong Jae Lee, et al.
Journal of Gynecologic Oncology|August 25, 2021
Comparisons of survival outcomes between bevacizumab and olaparib in <i>BRCA</i>-mutated, platinum-sensitive relapsed ovarian cancer: a Korean Gynecologic Oncology Group study (KGOG 3052)Se Ik Kim, Jeong-Won Lee, Kidong Kim, et al.
Gynecologic Oncology|August 7, 2019
Impact of laparoscopic radical hysterectomy on survival outcome in patients with FIGO stage IB cervical cancer: A matching study of two institutional hospitals in KoreaSe Ik Kim, Maria Lee, Sungyoung Lee, et al.
The American Journal of Surgical Pathology|March 26, 2025
Clinical Significance of Different Histology and High-Risk HPV Types in Neuroendocrine Carcinomas of the CervixSeung Jun Lee, Seokhyun Lee, Ilias P Nikas, et al.
BMC Cancer|December 8, 2020
Survival impact of extended cycles of second-line chemotherapy in platinum-sensitive relapsed ovarian cancer patients with residual tumor after six cyclesSe Ik Kim, Woo Yeon Hwang, Maria Lee, et al.
Pageof 14

Showing results (101-110 of 138) with videos related to

Sort By:
Pageof 14
Gynecologic Oncology|April 27, 2023
Conization before radical hysterectomy in patients with early-stage cervical cancer: A Korean multicenter study (COBRA-R)Se Ik Kim, So Hyun Nam, Suhyun Hwangbo, et al.
Cancer Letters|May 15, 2022
Integrated analysis of ascites and plasma extracellular vesicles identifies a miRNA-based diagnostic signature in ovarian cancerWenyu Wang, HyunA Jo, Sangick Park, et al.
Journal of Gynecologic Oncology|May 2, 2025
Current status and challenges in training the next generation of gynecologic cancer care providers in AsiaJyoti Meena, Dipanwita Banerjee, Se Ik Kim, et al.
Annals of Surgical Oncology|June 11, 2015
Comparison of Lower Extremity Edema in Locally Advanced Cervical Cancer: Pretreatment Laparoscopic Surgical Staging with Tailored Radiotherapy Versus Primary RadiotherapySe Ik Kim, Myong Cheol Lim, Jeong Seon Lee, et al.
BMC Cancer|November 23, 2021
Survival impact of additional chemotherapy after adjuvant concurrent chemoradiation in patients with early cervical cancer who underwent radical hysterectomySe Ik Kim, Jeong Yun Kim, Chan Woo Wee, et al.
Cancer Research and Treatment|March 21, 2025
Efficacy of Chemotherapy Following Prior PARP-Inhibitor Treatment in Patients with Ovarian CancerJung Chul Kim, Junsik Park, Yong Jae Lee, et al.
Journal of Gynecologic Oncology|August 25, 2021
Comparisons of survival outcomes between bevacizumab and olaparib in <i>BRCA</i>-mutated, platinum-sensitive relapsed ovarian cancer: a Korean Gynecologic Oncology Group study (KGOG 3052)Se Ik Kim, Jeong-Won Lee, Kidong Kim, et al.
Gynecologic Oncology|August 7, 2019
Impact of laparoscopic radical hysterectomy on survival outcome in patients with FIGO stage IB cervical cancer: A matching study of two institutional hospitals in KoreaSe Ik Kim, Maria Lee, Sungyoung Lee, et al.
The American Journal of Surgical Pathology|March 26, 2025
Clinical Significance of Different Histology and High-Risk HPV Types in Neuroendocrine Carcinomas of the CervixSeung Jun Lee, Seokhyun Lee, Ilias P Nikas, et al.
BMC Cancer|December 8, 2020
Survival impact of extended cycles of second-line chemotherapy in platinum-sensitive relapsed ovarian cancer patients with residual tumor after six cyclesSe Ik Kim, Woo Yeon Hwang, Maria Lee, et al.
Pageof 14